| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients
|
Oosten, Astrid W.
|
|
2016
|
56 |
7 |
p. 733-746
|
article
|
| 2 |
Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide
|
Brønden, Andreas
|
|
2017
|
56 |
7 |
p. 719-731
|
article
|
| 3 |
Clinical Pharmacokinetics and Pharmacodynamics of Cediranib
|
Tang, Weifeng
|
|
2016
|
56 |
7 |
p. 689-702
|
article
|
| 4 |
Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies
|
Goldwater, Ronald
|
|
2017
|
56 |
7 |
p. 803-813
|
article
|
| 5 |
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients
|
Radke, Christian
|
|
2016
|
56 |
7 |
p. 759-779
|
article
|
| 6 |
Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
|
Zhu, Tong
|
|
2016
|
56 |
7 |
p. 747-757
|
article
|
| 7 |
Effect of Activated Charcoal on Rivaroxaban Complex Absorption
|
Ollier, Edouard
|
|
2016
|
56 |
7 |
p. 793-801
|
article
|
| 8 |
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling
|
Snoeys, Jan
|
|
2016
|
56 |
7 |
p. 781-792
|
article
|
| 9 |
Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes
|
Scheen, André J.
|
|
2016
|
56 |
7 |
p. 703-718
|
article
|
| 10 |
Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options
|
Leeuwen, Roelof W. F. van
|
|
2017
|
56 |
7 |
p. 683-688
|
article
|
Journal description